Suggestions
Marcus Droege
VP & Global Head of Real World Evidence at bluebird bio
Marcus Droege is a seasoned biopharmaceutical executive with over 20 years of experience in various roles, including commercial strategy, market access, and real-world evidence (RWE) development. He holds both a Ph.D. and an MBA, which complement his extensive background in health economics and outcomes research (HEOR) and market access strategies across multiple therapeutic areas such as oncology, immunology, and neurology.
Professional Background
- Current Role: As of August 2020, Marcus served as the Vice President and Global Head of Real World Evidence (RWE) and Phase IV Research at bluebird bio until December 2021. In this role, he was responsible for leading initiatives that leverage real-world data to inform clinical development and market access strategies.1
- Previous Experience: Before his tenure at bluebird bio, he held significant positions at Novartis Gene Therapies as the Global Head of RWE and at Celgene as Head of Knowledge, Evidence & Access. His earlier career included leadership roles in market access at Passage Bio and PharmaConcepts.12
Expertise and Contributions
Marcus is recognized for his strategic leadership in securing formulary access to innovative therapies and has been instrumental in global product launches. His work involves extensive collaboration with regulatory bodies, payers, and health technology assessment (HTA) organizations worldwide. He has authored over 50 peer-reviewed publications and is known for his thought leadership in HEOR.12
Recent Developments
In July 2024, Droege was appointed Chief Commercial Officer at Muvon Therapeutics AG, where he will lead the company's global commercial strategy as it advances its innovative therapies for stress urinary incontinence.2
Skills and Attributes
- Multilingual: Fluent in English, German, and French.
- Leadership: Known for his ability to unify teams around shared goals and foster a culture of performance.
- Global Experience: Extensive experience working across markets in the U.S., Europe, Asia-Pacific, and South America.
Marcus Droege's career reflects a commitment to advancing innovative treatments through strategic market access and evidence generation.